Close Lucintel Chat
Didn't Find What You're Looking for?
Call us at +1972 636 5056 or write at helpdesk@Lucintel.com
Ask an Expert Provide Custom Requirements Download Sample Report Search Available Reports
  • helpdesk@Lucintel.com
  • |
  • Call Lucintel +1 972 636 5056
  • |
  • Login
  • |
  • Register
  • |
  • Search
  • |
'
...

The Impact of COVID-19 is included in Subcutaneous Drug Delivery Device Market. Buy it today to get an advantage.

Request the impact of COVID-19 on your product or industry


Subcutaneous Drug Delivery Device Market Trends and Forecast

The future of the global subcutaneous drug delivery device market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels. The global subcutaneous drug delivery device market is expected to reach an estimated $49.9 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunisation campaign.
  • Lucintel forecasts that pen injector will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost effectiveness, and high societal acceptance.
  • Retail pharmacy is expected to remain the largest segment due to patients’ growing preference for physical pharmacies owing to quick availability of medication and expanding number of retail pharmacies.
  • North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.
Subcutaneous Drug Delivery Device Market by Product, and Distribution Channel
A more than 150-page report is developed to help in your business decisions.  Sample figures with some insights are shown below. 
Subcutaneous Drug Delivery Device Market by Segments

North America will remain the largest region in the Subcutaneous Drug Delivery Device Market

  1. United States: Companies like Hexcel and Toray Industries are investing in advanced composites for aerospace and automotive applications. The government's National Composites Initiative funds research and development in composite materials. 
  2. China: Chinese firms including Shanghai SGL and Kingfa Science & Technology are expanding production capacities for advanced composites to meet domestic and global demand. Government initiatives like "Made in China 2025" drive investment in high-tech industries including composites.
  3. Germany: German companies like SGL Carbon and Covestro are innovating in advanced composite materials for automotive lightweighting and renewable energy sectors. Government support for research and development in advanced manufacturing technologies boosts market growth.
  4. Japan: Japanese manufacturers such as Mitsubishi Chemical and Toray Industries are leading in advanced composites for aerospace and electronics. Government initiatives like the Aerospace Innovation Strategy promote collaboration between industry and academia in composite research. 
  5. France: French companies like Safran and Arkema are focusing on advanced composites for aerospace and defense applications. Government initiatives such as the Future Investment Program fund research in advanced materials and technologies

Subcutaneous Drug Delivery Device Market by Segment

The study includes a forecast for the global subcutaneous drug delivery device market by product, distribution channel, and region, as follows:

Subcutaneous Drug Delivery Device Market by Product [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Prefilled Syringes
  • Pen Injectors
  • Auto-Injectors
  • Wearable Injectors
  • Needle-Free Injectors

Subcutaneous Drug Delivery Device Market by Distribution Channel [Value ($B) Shipment Analysis from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Subcutaneous Drug Delivery Device Market by Region [Value ($B) Shipment Analysis from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Subcutaneous Drug Delivery Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies subcutaneous drug delivery device companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the subcutaneous drug delivery device companies profiled in this report include. 

Recent Developments in Subcutaneous Drug Delivery Device Market 

  1. Advancements in Wearable Subcutaneous Drug Delivery Devices: Recent developments in the subcutaneous drug delivery device market include advancements in wearable devices for continuous drug delivery. Companies like Medtronic and Insulet are developing wearable insulin pumps and continuous glucose monitoring (CGM) systems that integrate subcutaneous drug delivery with real-time monitoring and data analytics capabilities, enhancing diabetes management for patients.
  2. Introduction of Smart Injection Pens: Smart injection pens equipped with connectivity features and digital health tracking capabilities are gaining traction in the market. Companies like Novo Nordisk and Eli Lilly are launching smart injection pen devices that allow patients to track insulin doses, monitor injection sites, and receive reminders for medication adherence, improving patient engagement and treatment outcomes. 
  3. Expansion of Subcutaneous Biologics Delivery Platforms: The subcutaneous drug delivery device market is witnessing an expansion of platforms for delivering biologic drugs. Companies like Amgen and Roche are developing innovative delivery systems, such as prefilled syringes, autoinjectors, and on-body infusors, for subcutaneous administration of biologic therapies targeting various diseases, including cancer, autoimmune disorders, and chronic inflammatory conditions. 
  4. Integration of Digital Health Solutions: Digital health solutions are being integrated into subcutaneous drug delivery devices to improve patient adherence, remote monitoring, and disease management. Companies like BD and West Pharmaceutical Services are collaborating with digital health platforms to develop connected drug delivery devices that enable data sharing between patients, healthcare providers, and caregivers, facilitating personalized treatment plans and remote support. 
  5. Focus on Patient-Centric Design: Manufacturers are focusing on patient-centric design principles to enhance the usability, comfort, and safety of subcutaneous drug delivery devices. Human factors engineering and patient feedback are guiding the development of devices with features such as ergonomic grips, intuitive user interfaces, and needle safety mechanisms, ensuring a positive user experience and minimizing the risk of errors or adverse events.
  6. Regulatory Approvals for Novel Subcutaneous Drug Delivery Technologies: Regulatory agencies such as the FDA and EMA are granting approvals for novel subcutaneous drug delivery technologies, paving the way for market expansion and adoption. Recent approvals include innovative devices for delivering biologic therapies, long-acting injectable medications, and patient-controlled infusion systems, providing patients with more options for managing their health conditions safely and effectively.

Features of the Subcutaneous Drug Delivery Device Market

  • Market Size Estimates: Subcutaneous drug delivery device market size estimation in terms of value ($B)
  • Trend And Forecast Analysis: Market trends (2018-2023) and forecast (2024-2030) by various segments and regions.
  • Segmentation Analysis: Subcutaneous drug delivery device market size by various segments, such as by product, distribution channel, and region
  • Regional Analysis: Subcutaneous drug delivery device market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by product, distribution channel, and regions for the subcutaneous drug delivery device market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the subcutaneous drug delivery device market.
  • Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the subcutaneous drug delivery device market size?
Answer: The global subcutaneous drug delivery device market is expected to reach an estimated  $49.9 billion by 2030.
Q2. What is the growth forecast for subcutaneous drug delivery device market?
Answer: The global subcutaneous drug delivery device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the subcutaneous drug delivery device market?
Answer: The major drivers for this market are increasing number of cases for diabetes and cardiovascular diseases (CVD) and expanding use of these delivery systems for various biomedical drug advances and immunisation campaign.
Q4. What are the major segments for subcutaneous drug delivery device market?
Answer: The future of the subcutaneous drug delivery device market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels.
Q6. Who are the key subcutaneous drug delivery device companies?
Answer: Some of the key subcutaneous drug delivery device companies are as follows:
  • Gerresheimer
  • Medtronic
  • Ypsomed
  • Elcam Medical Group
  • Novo Nordisk
Q7. Which subcutaneous drug delivery device segment will be the largest in future?
Answer: Lucintel forecasts that pen injector will remain the largest segment over the forecast period due to its expanding usage because of its easy-to-use features, easily availability, cost-effectiveness, and high societal acceptance.
Q8. In subcutaneous drug delivery device market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to presence of advanced healthcare infrastructure, introduction of needle-free subcutaneous drug delivery device, and growing number of chronic disease cases in the region.
Q9. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the subcutaneous drug delivery device market by product (prefilled syringes, pen injectors, auto-injectors, wearable injectors, and needle-free injectors), distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
 
For any questions related to subcutaneous drug delivery device market or related to subcutaneous drug delivery device companies, subcutaneous drug delivery device market size, subcutaneous drug delivery device market share, subcutaneous drug delivery device analysis, subcutaneous drug delivery device market growth, subcutaneous drug delivery device market research, write Lucintel analyst at email: helpdesk@lucintel.com we will be glad to get back to you soon.
Table of Contents
 
1. Executive Summary
 
2. Global Subcutaneous Drug Delivery Device Market: Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
 
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1: Macroeconomic Trends (2018-2030) and Forecast (2024-2030)
3.2: Global Subcutaneous Drug Delivery Device Market Trends (2018-2030) and Forecast (2024-2030)
3.3: Global Subcutaneous Drug Delivery Device Market by Product
3.3.1: Prefilled Syringes
3.3.2: Pen Injectors
3.3.3: Auto-Injectors
3.3.4: Wearable Injectors
3.3.5: Needle-Free Injectors
3.4: Global Subcutaneous Drug Delivery Device Market by Distribution Channel
3.4.1: Hospital Pharmacies
3.4.2: Retail Pharmacies
3.4.3: Online Pharmacies  
 
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Subcutaneous Drug Delivery Device Market by Region
4.2: North American Subcutaneous Drug Delivery Device Market
4.2.1: North American Subcutaneous Drug Delivery Device Market by Product: Prefilled Syringes, Pen Injectors, Auto-Injectors, Wearable Injectors, and Needle-Free Injectors
4.2.2: North American Subcutaneous Drug Delivery Device Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.3: European Subcutaneous Drug Delivery Device Market
4.3.1: European Subcutaneous Drug Delivery Device Market by Product: Prefilled Syringes, Pen Injectors, Auto-Injectors, Wearable Injectors, and Needle-Free Injectors
4.3.2: European Subcutaneous Drug Delivery Device Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.4: APAC Subcutaneous Drug Delivery Device Market 
4.4.1: APAC Subcutaneous Drug Delivery Device Market by Product: Prefilled Syringes, Pen Injectors, Auto-Injectors, Wearable Injectors, and Needle-Free Injectors
4.4.2: APAC Subcutaneous Drug Delivery Device Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
4.5: ROW Subcutaneous Drug Delivery Device Market 
4.5.1: ROW Subcutaneous Drug Delivery Device Market by Product: Prefilled Syringes, Pen Injectors, Auto-Injectors, Wearable Injectors, and Needle-Free Injectors
4.5.2: ROW Subcutaneous Drug Delivery Device Market by Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies
 
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
 
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Subcutaneous Drug Delivery Device Market by Product
6.1.2: Growth Opportunities for the Global Subcutaneous Drug Delivery Device Market by Distribution Channel
6.1.3: Growth Opportunities for the Global Subcutaneous Drug Delivery Device Market by Region
6.2: Emerging Trends in the Global Subcutaneous Drug Delivery Device Market 
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Subcutaneous Drug Delivery Device Market 
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Subcutaneous Drug Delivery Device Market 
6.3.4: Certification and Licensing
 
7. Company Profiles of Leading Players
7.1: Gerresheimer
7.2: Medtronic
7.3: Ypsomed
7.4: Elcam Medical Group 
7:5: Novo Nordisk
 
.

Buy full report or by chapter as follows

Price by License Type:
[-] Hide Chapter Details
[Chapter Number] [Chapter Name] [Chapter Number Of Pages] [Chapter Price]
Title/Chapter Name Pages Price
Full Report: Subcutaneous Drug Delivery Device Market: Trends, Opportunities and Competitive Analysis [2024-2030] Full Report $ 4,850
150 - page report
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
  • In-depth interviews of the major players in this market
  • Detailed secondary research from competitors’ financial statements and published data 
  • Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
  • A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
 
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process. 
 

Please sign in below to get report brochure - Subcutaneous Drug Delivery Device Market.

At Lucintel, we respect your privacy and maintain the confidentiality of information / data provided by you
(Please enter your corporate email. * These fields are mandatory )
Have an Account / Returning Visitors?